86 related articles for article (PubMed ID: 22149451)
1. Thrombin generation and platelet activation related to subintimal percutaneous transluminal angioplasty.
Jenssen EK; Brosstad F; Pedersen T; Bjørnsen S; Jørgensen JJ; Sandbæk G
Scand J Clin Lab Invest; 2012 Feb; 72(1):23-8. PubMed ID: 22149451
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation increases with the severity of peripheral arterial disease: implications for clinical management.
Rajagopalan S; Mckay I; Ford I; Bachoo P; Greaves M; Brittenden J
J Vasc Surg; 2007 Sep; 46(3):485-90. PubMed ID: 17826235
[TBL] [Abstract][Full Text] [Related]
3. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
[TBL] [Abstract][Full Text] [Related]
5. Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty.
Bunescu A; Widman J; Lenkei R; Menyes P; Levin K; Egberg N
Clin Sci (Lond); 2002 Mar; 102(3):279-86. PubMed ID: 11869168
[TBL] [Abstract][Full Text] [Related]
6. Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis.
Gremmel T; Ay C; Riedl J; Kopp CW; Eichelberger B; Koppensteiner R; Panzer S
Thromb Haemost; 2016 Mar; 115(3):615-21. PubMed ID: 26467184
[TBL] [Abstract][Full Text] [Related]
7. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
8. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4.
Panasiuk A; Prokopowicz D; Zak J; Matowicka-Karna J; Osada J; Wysocka J
Hepatogastroenterology; 2001; 48(39):818-22. PubMed ID: 11462931
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions.
Boufi M; Dona B; Orsini B; Auquier P; Hartung O; Alimi YS
J Vasc Surg; 2010 Nov; 52(5):1211-7. PubMed ID: 20692789
[TBL] [Abstract][Full Text] [Related]
10. [A study of platelet activation following coronary angioplasty. Effect on acute occlusion and restenosis].
Durrieu-Jaïs C; Macchi L; Bihour C; Coste P; Besse P; Nurden P; Nurden AT
Arch Mal Coeur Vaiss; 1996 Oct; 89(10):1259-65. PubMed ID: 8952823
[TBL] [Abstract][Full Text] [Related]
11. Platelet depletion, platelet activation and coagulation during treatment with hemodialysis.
Schoorl M; Schoorl M; Nubé MJ; Bartels PC
Scand J Clin Lab Invest; 2011 May; 71(3):240-7. PubMed ID: 21303224
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric assessment of platelet function in patients with peripheral arterial occlusive disease.
Galt SW; McDaniel MD; Ault KA; Mitchell J; Cronenwett JL
J Vasc Surg; 1991 Dec; 14(6):747-55; discussion 755-6. PubMed ID: 1720468
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?
Mickelson JK; Lakkis NM; Villarreal-Levy G; Hughes BJ; Smith CW
J Am Coll Cardiol; 1996 Aug; 28(2):345-53. PubMed ID: 8800108
[TBL] [Abstract][Full Text] [Related]
14. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
Riba R; Nicolaou A; Troxler M; Homer-Vaniasinkam S; Naseem KM
Atherosclerosis; 2004 Jul; 175(1):69-75. PubMed ID: 15186948
[TBL] [Abstract][Full Text] [Related]
15. Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease.
Gremmel T; Koppensteiner R; Ay C; Panzer S
Eur J Clin Invest; 2014; 44(3):319-24. PubMed ID: 24382127
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Mobarrez F; He S; Bröijersen A; Wiklund B; Antovic A; Antovic J; Egberg N; Jörneskog G; Wallén H
Thromb Haemost; 2011 Aug; 106(2):344-52. PubMed ID: 21614411
[TBL] [Abstract][Full Text] [Related]
17. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD40L in peripheral artery disease. Relationship with disease severity, platelet markers and the effects of angioplasty.
Blann AD; Tan KT; Tayebjee MH; Davagnanam I; Moss M; Lip GY
Thromb Haemost; 2005 Mar; 93(3):578-83. PubMed ID: 15735813
[TBL] [Abstract][Full Text] [Related]
19. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease.
Tsakiris DA; Tschöpl M; Wolf F; Labs KH; Jäger KA; Marbet GA
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):165-73. PubMed ID: 10759010
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous oximetry compared to ankle-brachial-index measurement in the evaluation of percutaneous transluminal angioplasty.
Wildgruber M; Wolf O; Weiss W; Berger H; Lutzenberger W; Eckstein HH; Heider P
Eur J Radiol; 2007 Nov; 64(2):302-8. PubMed ID: 17386992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
